What it sells
The AI-native platform for next-generation protein characterization.
Business model breakdown
Workflow: what inputs become what output?
Peptide mapping for protein therapeutics with 10x faster processing and no file conversions.
Funding history and coverage
| Round date | Stage | Amount | Investors | Source |
|---|---|---|---|---|
| — | Y Combinator Winter 2026 | — | Y Combinator | ycombinator.com |
Profiles summarize public reporting and company websites. Business-model notes are MaxBC's reading of that material, not confirmed facts; unknowns are left blank rather than guessed. Updated 2026-10-12.